Sandostatin
- Product NDC
- 0078-0182
- 11-digit product format
- 000780182
- Labeler code
- 0078
- Product ID
- 0078-0182_ad42b59d-8ad5-4855-96a9-f40c7ef4a7e3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- octreotide acetate
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS; SUBCUTANEOUS
- Labeler
- Novartis Pharmaceuticals Corporation
- Application
- NDA019667
- Marketing category
- NDA
- Marketing start
- 1988-10-21
- Substance
- OCTREOTIDE ACETATE
- Active strength
- 500 ug/mL
- Pharmacologic classes
- Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Sandostatin
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| OCTREOTIDE ACETATE | 500 ug/mL |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | 75R0U2568I |
| Rxcui | 207194, 207198, 207200, 312068, 312069, 312070 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0078-0182-01 | Sandostatin | 10 in 1 PACKAGE | INJECTION, SOLUTION | 10 | 22 | |
| 0078-0182-61 | Sandostatin | 1 mL in 1 AMPULE | INJECTION, SOLUTION | 1 | 22 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0078-0182-01 | ML - Milliliter | 0078-0182 | bd523ca5-34ba-47f2-a31d-fac6262b0dda | 1 | 2012-07-24 |
| 0078-0182-61 | ML - Milliliter | 0078-0182 | 742db355-5848-416a-bcf4-e083b33a56e2 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| OCTREOTIDE ACETATE | ACTIVE INGREDIENT | 75R0U2568I | SANDOSTATIN (OCTREOTIDE ACETATE) INJECTION, SOLUTION [NOVARTIS PHARMACEUTICALS CORPORATION] | 7 | |
| OCTREOTIDE | ACTIVE MOIETY | RWM8CCW8GP | SANDOSTATIN (OCTREOTIDE ACETATE) INJECTION, SOLUTION [NOVARTIS PHARMACEUTICALS CORPORATION] | 7 | |
| LACTIC ACID | INACTIVE INGREDIENT | 33X04XA5AT | SANDOSTATIN (OCTREOTIDE ACETATE) INJECTION, SOLUTION [NOVARTIS PHARMACEUTICALS CORPORATION] | 7 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | SANDOSTATIN (OCTREOTIDE ACETATE) INJECTION, SOLUTION [NOVARTIS PHARMACEUTICALS CORPORATION] | 7 | |
| PHENOL | INACTIVE INGREDIENT | 339NCG44TV | SANDOSTATIN (OCTREOTIDE ACETATE) INJECTION, SOLUTION [NOVARTIS PHARMACEUTICALS CORPORATION] | 7 | |
| SODIUM BICARBONATE | INACTIVE INGREDIENT | 8MDF5V39QO | SANDOSTATIN (OCTREOTIDE ACETATE) INJECTION, SOLUTION [NOVARTIS PHARMACEUTICALS CORPORATION] | 7 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | SANDOSTATIN (OCTREOTIDE ACETATE) INJECTION, SOLUTION [NOVARTIS PHARMACEUTICALS CORPORATION] | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 312069 | octreotide 100 MCG in 1 ML Injection | PSN | 4e2c9856-1836-49f0-9472-4dbeeb408f39 | 22 |
| 312068 | octreotide 50 MCG in 1 ML Injection | PSN | 4e2c9856-1836-49f0-9472-4dbeeb408f39 | 22 |
| 312070 | octreotide 500 MCG in 1 ML Injection | PSN | 4e2c9856-1836-49f0-9472-4dbeeb408f39 | 22 |
| 207198 | SandoSTATIN 100 MCG in 1 ML Injection | PSN | 4e2c9856-1836-49f0-9472-4dbeeb408f39 | 22 |
| 207194 | SandoSTATIN 50 MCG in 1 ML Injection | PSN | 4e2c9856-1836-49f0-9472-4dbeeb408f39 | 22 |
| 207200 | SandoSTATIN 500 MCG in 1 ML Injection | PSN | 4e2c9856-1836-49f0-9472-4dbeeb408f39 | 22 |
| 207194 | 1 ML octreotide 0.05 MG/ML Injection [Sandostatin] | SBD | 4e2c9856-1836-49f0-9472-4dbeeb408f39 | 22 |
| 207198 | 1 ML octreotide 0.1 MG/ML Injection [Sandostatin] | SBD | 4e2c9856-1836-49f0-9472-4dbeeb408f39 | 22 |
| 207200 | 1 ML octreotide 0.5 MG/ML Injection [Sandostatin] | SBD | 4e2c9856-1836-49f0-9472-4dbeeb408f39 | 22 |
| 312068 | 1 ML octreotide 0.05 MG/ML Injection | SCD | 4e2c9856-1836-49f0-9472-4dbeeb408f39 | 22 |
| 312069 | 1 ML octreotide 0.1 MG/ML Injection | SCD | 4e2c9856-1836-49f0-9472-4dbeeb408f39 | 22 |
| 312070 | 1 ML octreotide 0.5 MG/ML Injection | SCD | 4e2c9856-1836-49f0-9472-4dbeeb408f39 | 22 |
| 312069 | 1 ML octreotide 100 MCG/ML Injection | SY | 4e2c9856-1836-49f0-9472-4dbeeb408f39 | 22 |
| 312070 | 1 ML octreotide 500 MCG/ML Injection | SY | 4e2c9856-1836-49f0-9472-4dbeeb408f39 | 22 |
| 207194 | 1 ML Sandostatin 0.05 MG/ML Injection | SY | 4e2c9856-1836-49f0-9472-4dbeeb408f39 | 22 |
| 207198 | 1 ML Sandostatin 0.1 MG/ML Injection | SY | 4e2c9856-1836-49f0-9472-4dbeeb408f39 | 22 |
| 207200 | 1 ML Sandostatin 0.5 MG/ML Injection | SY | 4e2c9856-1836-49f0-9472-4dbeeb408f39 | 22 |
| 312069 | octreotide 100 MCG per 1 ML Injection | SY | 4e2c9856-1836-49f0-9472-4dbeeb408f39 | 22 |
| 312068 | octreotide 50 MCG per 1 ML Injection | SY | 4e2c9856-1836-49f0-9472-4dbeeb408f39 | 22 |
| 312070 | octreotide 500 MCG per 1 ML Injection | SY | 4e2c9856-1836-49f0-9472-4dbeeb408f39 | 22 |
| 207198 | Sandostatin 100 MCG per 1 ML Injection | SY | 4e2c9856-1836-49f0-9472-4dbeeb408f39 | 22 |
| 207200 | Sandostatin 500 MCG per 1 ML Injection | SY | 4e2c9856-1836-49f0-9472-4dbeeb408f39 | 22 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 0078-0182-01 | 00078018201 | 10 AMPULE in 1 PACKAGE (0078-0182-01) / 1 mL in 1 AMPULE (0078-0182-61) | 10 ampule | 1988-10-21 | 0000-00-00 | No | No | Current |
| 0078-0182-61 | 00078018261 | 1 mL in 1 AMPULE | 1 ml | Historical |